Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children
PARTAGE
1 other identifier
observational
1,347
1 country
1
Brief Summary
Insufficient screening and diagnostic delay play a significant role in sustaining the HIV epidemic by France. Gender inequalities major factors reinforce social inequalities in order to of heterosexual men born abroad the most later diagnosed with HIV infection. Those gender differences are largely due to efficiency antenatal HIV screening, offered to women every pregnancy and widely accepted: a billed HIV serology in the context of pregnancy monitoring was found for 92% pregnant women benefiting from health insurance in 2015 the health of men is not taken into account in prenatal follow-up current French. The maternity hospital drains a population largely immigrant, often precarious The male prenatal consultation exists but it is not organized: it is possible to implement it, provided that the constraints exerted on men are taken into account. the projet study the feasibility and the implementation processes place of prenatal consultation of future fathers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2021
CompletedFirst Submitted
Initial submission to the registry
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
October 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedApril 3, 2025
March 1, 2025
1.2 years
September 27, 2021
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
evaluation of the proportion of fathers-to-be who fathers who accepted prenatal consultation among
Study the feasibility and processes of setting up the prenatal consultation of future fathers, through the different modalities proposed (in the maternity ward, elsewhere in the hospital, in the heart of city; during the day or in the evening; with or without an appointment) over a period of 26 months at the hospital intercommunal of Montreuil.
6 months
Secondary Outcomes (2)
impact of male counselling on testing for HIV and other infections
6 months
impact of male consultation on vaccination coverage,
6 months
Eligibility Criteria
The population targeted by the data collection is the same as the population targeted by the intervention. Are eligible for a prenatal consultation all men living in Ile de France including the companion is followed at the intercommunal hospital of Montreuil for a progressive pregnancy. Women are also targeted by data collection. All women are eligible newly enrolled in the maternity ward of the Montreuil intercommunal hospital centre for a progressive pregnancy declaring a partner involved in the pregnancy and residing in Ile de France.
You may qualify if:
- For future fathers
- are eligible for a prenatal consultation all adult men living in Ile de France whose companion is followed at the intercommunal hospital of Montreuil for a pregnancy Evolutionary.
- having expressed no opposition to participation in the research
- For future mothers
- all adult women newly enrolled in the maternity ward of the Montreuil intercommunal hospital centre for a progressive pregnancy declaring a partner involved in pregnancy and residing in Ile de France.
- having expressed no opposition to participation in the research
You may not qualify if:
- Persons who are unable to give their non-opposition due to a poor understanding of the French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pauline Penot
Montreuil, 93100, France
Related Publications (3)
Piffaretti C, Looten V, Rey S, Fresson J, Fagot-Campagna A, Tuppin P. Management of pregnancy based on healthcare consumption of women who delivered in France in 2015: Contribution of the national health data system (SNDS). J Gynecol Obstet Hum Reprod. 2018 Sep;47(7):299-307. doi: 10.1016/j.jogoh.2018.05.014. Epub 2018 Jun 2.
PMID: 29870831BACKGROUNDKigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, Emenyonu NI, Bangsberg DR, Hahn JA. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):280-9. doi: 10.1097/QAI.0b013e3181ab6eab.
PMID: 19521248BACKGROUNDPenot P, Jacob G, Guerizec A, Trevisson C, Letembet VA, Harich R, Phuong T, Renevier B, Manuellan PE, du Lou AD; Partage Study Group. Implementing a prenatal health screening intervention for future fathers in Montreuil, France: most users are immigrants facing hardship. BMC Public Health. 2024 Oct 28;24(1):2982. doi: 10.1186/s12889-024-20388-x.
PMID: 39468472DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2021
First Posted
October 20, 2021
Study Start
March 17, 2021
Primary Completion
June 10, 2022
Study Completion
June 10, 2022
Last Updated
April 3, 2025
Record last verified: 2025-03